Assessment of Psilocybin (TRP-8802) in Concert With Psychotherapy in Patients With Irritable Bowel Syndrome (IBS)

Recruiting

Phase 2

Psilocybin with PsychotherapyAssessment of Psilocybin (TRP-8802) in Concert With Psychotherapy in Patients With Irritable Bowel Syndrome (IBS)

Sponsor:

TRYP Therapeutics

Code:

NCT06206265

Conditions

Irritable Bowel Syndrome

Eligibility Criteria

Sex: All

Age: 21 - 64

Healthy Volunteers: Not accepted

Interventions

TRYP-0082

Psychotherapy

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-19. This information was provided to ClinicalTrials.gov by TRYP Therapeutics on 2024-01-19.